万邦医药 (301520.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(万邦医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度
单季度财务指标:
 单季度每股收益(元) ---1.00-1.00--
 单季度销售毛利率(%) 47.0043.0051.0051.0053.0049.0053.00-
 单季度销售净利率(%) 33.0030.0031.0031.0035.0037.0046.00-
 单季度净资产收益率ROE(%) 2.002.003.008.007.00---
 单季度总资产净利率ROA(%) 2.002.002.006.006.00---
单季度财务摘要:
 单季度营业总收入(元) 90,172,342.00101,152,905.0075,661,205.0092,933,999.0072,058,424.0080,418,859.0072,723,218.00-
 单季度营业总成本(元) 65,349,752.0071,286,156.0054,900,457.0060,366,122.0044,258,960.0048,323,729.0042,682,979.00-
 单季度营业收入(元) 90,172,342.00101,152,905.0075,661,205.0092,933,999.0072,058,424.0080,418,859.0072,723,218.00-
 单季度营业利润(元) 32,127,485.0033,431,285.0025,094,289.0031,976,222.0028,504,379.0029,868,094.0037,719,785.00-
 单季度利润总额(元) 32,375,767.0033,701,554.0025,242,122.0032,260,569.0028,440,664.0032,745,391.0037,716,264.00-
 单季度净利润(元) 29,687,084.0030,780,385.0023,490,906.0028,833,380.0024,987,178.0029,807,736.0033,100,698.00-
 单季度归属母公司股东的净利润(元) 29,687,084.0030,780,385.0023,490,906.0028,833,380.0024,987,178.0029,807,736.0033,100,698.00-
 单季度经营活动产生的现金流量(元) 566,206.0022,449,601.0013,797,169.0032,604,561.003,073,452.0023,091,363.0025,513,395.0029,664,913.00
 单季度投资活动产生的现金流量(元) -15,317,844.00-814,670,489.00-166,788,886.00-21,946,659.00-29,294,592.00-23,815,879.00-18,476,733.00-
 单季度筹资活动产生的现金流量(元) --5,957,880.001,034,105,946.00--30,000.00---
 单季度现金及现金等价物净增加(元) -14,751,638.00-798,178,768.00881,114,229.0010,657,903.00-26,251,140.00-844,516.007,096,662.00-

前瞻产业研究院